Comparison of breast magnetic resonance imaging clinical tumor size with pathologic tumor size in patients status post-neoadjuvant chemotherapy

American Journal of Surgery

Volumn 206, Issue 4, 2013, Pages 567-573

  Williams, Mindy ^a   Eatrides, Jennifer ^a   Kim, Jongphil ^a   Talwar, Harpreet ^a   Esposito, Nicole ^a   Szabunio, Margaret ^a   Ismail Khan, Roohi ^a   Kiluk, John ^a   Lee, Marie ^a   Laronga, Christine ^a   Khakpour, Nazanin ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Magnetic resonance imaging; Neoadjuvant chemotherapy

Indexed keywords

ANTHRACYCLINE; TAXANE DERIVATIVE; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME;

BREAST CANCER; MAGNETIC RESONANCE IMAGING; NEOADJUVANT CHEMOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; PREDICTIVE VALUE OF TESTS; RECEPTOR, ERBB-2; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84885048921     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2013.02.006     Document Type: Article

References (37)

1. J.H. Chen, B.A. Feig, D.J. Hsiang, and et al Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer Ann Surg 249 2009 448 454
2. S.C. Partridge, J.E. Gibbs, and Y. Lu MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival AJR Am J Roentgenol 184 2005 1774 1781
3. B. Fisher, A. Brown, and E. Mamounas Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 1997 2483 2493
4. G. Calais, C. Berger, and P. Descamps Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm Cancer 74 1997 1283 1288
5. J. Pierga, S. Delaloge, and M. Espie A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients Breast Cancer Res Treat 122 2010 429 437
6. S.E. Singletary, M.D. McNeese, and G.N. Hortobagyi Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma Cancer 69 1992 2849 2852
7. A.E. Makris, T.J. Powles, and S.E. Ashley A reduction in the requirements for mastectom y in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer Ann Oncol 9 1998 1179 1184
8. J.A. van der Hage, C.J. van de Velde, and J.P. Julien Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer Trail 10902 J Clin Oncol 19 2001 4224 4237
9. P. Rastogi, S.J. Anderson, and H.D. Bear Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 J Clin Oncol 26 2008 778 785
10. G.F. Schwartz, U. Veronesi, and K.B. Clough Consensus conference of breast conservation J Am Coll Surg 203 2006 198 207
11. B. Fisher, and S. Anderson Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials. National Surgical Adjuvant Breast and Bowel Project World J Surg 18 1994 63 69
12. L.A. Newman, and Kuerer HM Advances in breast conservation therapy J Clin Oncol 23 2005 1685 1697
13. A.M. Chen Breast conservation after neoadjuvant chemotherapy: The M.D. Anderson Cancer Center Experience J Clin Oncol 22 2004 2303 2312
14. M. Kriege, C. Brekelmans, and P.E. Boetes Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 2004 427 437
15. F. Sardanelli, F. Podo, and G. D'Agnolo Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results Radiology 242 2007 698 715
16. C.D. Lehman, C. Gatsonis, and C.K. Kuhl MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer N Engl J Med 356 2007 1295 1303
17. D. Segara, I.E. Krop, and J.E. Garber Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy? J Surg Oncol 96 2007 474 480
18. N.M. Hylton, J.D. Blume, and W.K. Bernreuter Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy-results from ACRIN 6657/I-SPY TRIAL Radiology 263 2012 663 672
19. J.H. Chen, B. Feig, and G. Agrawal MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy Cancer 112 2008 17 26
20. E.L. Rosen, K.L. Blackwell, and J.A. Baker Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy AJR Am J Roentgenol 181 2003 1275 1282
21. M. Morrow Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm J Clin Oncol 26 2008 352 353
22. National Cancer Institute: RECIST Criteria J Clin Oncol 26 2008 352 353
23. K. Ogston, I.D. Miller, and S. Payne A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival Breast 12 2003 320 327
24. S. Chaturvedi Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumor in the breast? Breast Cancer Res Treat 93 2005 151 158
25. R. Rouzier, J.M. Extra, and M. Carton Primary chemotherapy for operable breast cancer: Incidence and prognostic significance of ipsilateral breast tumor recurrence after breast conserving surgery J Clin Oncol 19 2001 3828 3835
26. F. Peintinger, W.F. Symmans, and A.M. Gonzalez-Angulo The safety of breast-conserving surgery in patients who receive a complete pathological response after neoadjuvant chemotherapy Cancer 107 2006 1248 1254
27. J.L. Oh, M.J. Dryden, and W.A. Woodward Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy J Clin Oncol 24 2006 4971 4975
28. A.M. Bosch, A.G. Kessels, and G.L. Beets Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours Eur J Radiol 48 2003 285 292
29. M. Beresford, A.R. Padhani, and V. Goh Imaging breast cancer response during neoadjuvant systemic therapy Expert Rev Anticancer Ther 5 2005 893 905
30. C. Laronga Neoadjuvant chemotherapy in stage III breast cancer Breast Diseases: A Year Book Quarterly 17 2006 96
31. H.J. Kim, Y.H. Im, and B.K. Han Accuracy of MRI for estimating residual tumor size after neoadjuvant chemotherapy in locally advanced breast cancer: relation to response patterns on MRI Acta Oncol 46 2007 996 1003
32. H.D. Bear, S. Anderson, and A. Brown The effect on tumor response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27 J Clin Oncol 21 2003 4165 4174
33. N. Allada, C.R. Osborne, and X-J. Xie Pathological and clinical outcomes in response to neoadjuvant chemotherapy: a comparison of basal-like, hormone receptor-positive and HER2-positive breast cancers Breast Cancer Res Treat 106 suppl 1 2007 S232 Abstract 5076
34. C.J. Christy, D. Thorsteinsson, and B.J. Grube Preoperative chemotherapy decreases the need for re-excision of breast cancers between 2 and 4 cm diameter Ann Surg Oncol 16 2009 697 702
35. J.F. Waljee, E.S. Hu, and L.A. Newman Predictors of re-excision among women undergoing breast-conserving surgery for cancer Ann Surg Oncol 15 2008 1297 1303
36. L. Jacobs Positive margins: the challenge continues for breast surgeons Ann Surg Oncol 15 2008 1271 1272
37. C.E. Cox, M. Hyacinthe, and R.J. Gonzalez Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: clinical outcome Ann Surg Oncol 4 1997 644 649